Heartburn drug joins fight against tough prostate cancer
NCT ID NCT04337580
Summary
This study is testing whether adding the common heartburn medication omeprazole to standard chemotherapy (cabazitaxel) helps control advanced prostate cancer that has stopped responding to other treatments. It will involve about 50 men whose cancer has progressed despite prior hormone therapy and chemotherapy. Researchers believe omeprazole might block a cancer fuel source, potentially making the chemotherapy more effective at shrinking tumors and easing bone pain.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
W.G. Bill Hefner VA Medical Center
RECRUITINGSalisbury, North Carolina, 28144, United States
Contact
Contact Email: •••••@•••••
-
Wake Forest Baptist Comprehensive Cancer Center
RECRUITINGWinston-Salem, North Carolina, 27157, United States
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.